Document Detail

Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer.
MedLine Citation:
PMID:  21393379     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: The purpose of this study is to evaluate the risk factors and the prevalence of thromboembolic events (TEEs) in breast cancer patients.
PATIENTS AND METHODS: This is a retrospective cohort study using the Surveillance, Epidemiology, and End Results-Medicare database. Breast cancer patients diagnosed from 1992 to 2005 ≥66 years old were identified. International Classification of Diseases, Ninth Revision, and Healthcare Common Procedure Coding System codes were used to identify TEEs within 1 year of the breast cancer diagnosis. Analyses were conducted using descriptive statistics and logistic regression.
RESULTS: A total of 89 841 patients were included, of them 2658 (2.96%) developed a TEE. In the multivariable analysis, males had higher risk of a TEE than women [odd ratio (OR) = 1.57; confidence interval (CI) 1.10-2.25] and blacks had higher risk than whites (OR = 1.20; CI 1.04-1.40). Compared with stage I patients, patients with stage II, III and IV had 22%, 39% and 98% increase, respectively, in risk. Placement of central catheters (OR = 2.71; CI 2.43-3.02), chemotherapy treatment (OR = 1.66; CI 1.48-1.86) or treatment with erythropoiesis-stimulating agents (ESAs) (OR = 1.33; CI 1.33-1.52) increase the risk. Other significant predictors included comorbidities, age, receptor status, marital status and year of diagnosis. Similar estimates were seen for pulmonary embolism, deep vein thromboembolism and other TEEs.
CONCLUSIONS: In total, 2.96% of patients in this cohort developed a TEE within 1 year from breast cancer diagnosis. Stage, gender, race, use of chemotherapy and ESAs, comorbidities, receptor status and catheter placement were associated with the development of TEEs.
M Chavez-MacGregor; H Zhao; M Kroll; S Fang; N Zhang; G N Hortobagyi; T A Buchholz; Y-C Shih; S H Giordano
Related Documents :
22065479 - Influence of uncommon histology on breast conservation therapy for breast cancer-biolog...
22034289 - High prevalence of brca1 and brca2 mutations in unselected nigerian breast cancer patie...
21618959 - The impact of lobular histology on breast cancer treatment.
21716849 - Targeting egfr in triple negative breast cancer.
1376429 - The use of the micronucleus test on exfoliated cells to identify anti-clastogenic actio...
15283899 - Delivering prostate cancer prevention messages to the public: how the national cancer i...
6212019 - Treatment of vaginal carcinoma with laser photoirradiation following administration of ...
15170249 - Augmentation mammaplasty: where should the implant be placed?
8606869 - Immunoreactive p53 protein in high-grade prostatic intraepithelial neoplasia.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2011-03-10
Journal Detail:
Title:  Annals of oncology : official journal of the European Society for Medical Oncology / ESMO     Volume:  22     ISSN:  1569-8041     ISO Abbreviation:  Ann. Oncol.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-10-25     Completed Date:  2011-12-19     Revised Date:  2013-06-30    
Medline Journal Info:
Nlm Unique ID:  9007735     Medline TA:  Ann Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  2394-402     Citation Subset:  IM    
Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Aged, 80 and over
Breast Neoplasms / blood,  epidemiology*,  pathology
Breast Neoplasms, Male / blood,  epidemiology*,  pathology
Neoplasm Staging
Risk Factors
SEER Program
Thromboembolism / epidemiology*,  etiology
United States / epidemiology
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  'These reforms killed me': doctors' perceptions of family medicine during the transition from commun...
Next Document:  Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III ran...